2015
DOI: 10.1038/nrc.2015.3
|View full text |Cite
|
Sign up to set email alerts
|

Biomaterials and emerging anticancer therapeutics: engineering the microenvironment

Abstract: The microenvironment is increasingly recognized to play key roles in cancer, and biomaterials provide a means to engineer microenvironments both in vitro and in vivo to study and manipulate cancer. In vitro cancer models using 3D matrices recapitulate key elements of the tumor microenvironment and have revealed new aspects of cancer biology. Cancer vaccines based on some of the same biomaterials have, in parallel, allowed for the engineering of durable prophylactic and therapeutic anticancer activity in precli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
291
0
5

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
2
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 367 publications
(297 citation statements)
references
References 182 publications
1
291
0
5
Order By: Relevance
“…Transwell ®), as well as immunofluorescent or immunohistochemical staining and imaging [4,19,20]. However, the inability of 2D culture to accurately predict therapeutic response and the complexity of animal models has paved the way for the development of 3D in vitro models, which utilize materials such as hydrogels to recapitulate elements of the tumor microenvironment [21][22][23]. To date, 3D in vitro models for GBM primarily incorporate only tumor cells, despite the demonstrated contributions of additional cell types to in vivo GBM behavior [6,[24][25][26][27][28][29][30].…”
Section: Introductionmentioning
confidence: 99%
“…Transwell ®), as well as immunofluorescent or immunohistochemical staining and imaging [4,19,20]. However, the inability of 2D culture to accurately predict therapeutic response and the complexity of animal models has paved the way for the development of 3D in vitro models, which utilize materials such as hydrogels to recapitulate elements of the tumor microenvironment [21][22][23]. To date, 3D in vitro models for GBM primarily incorporate only tumor cells, despite the demonstrated contributions of additional cell types to in vivo GBM behavior [6,[24][25][26][27][28][29][30].…”
Section: Introductionmentioning
confidence: 99%
“…With this combinatory approach, it will be possible to gain a more complete picture of the cancer microenvironment and ascertain potential avenues of treatment. Additionally, non-cell factors such as chemotaxis, 130 3D culture 94,[131][132][133][134][135][136] , and hypoxia 137 should be considered for future investigations, in conjunction with mechanical cues to create a microenvironment that can more fully recapitulate in vivo conditions. The study of ovarian cancer mechanotransduction promises to improve patient treatment through future investigations that utilize designs pertinent to the specific microenvironment.…”
Section: Discussionmentioning
confidence: 99%
“…Molecular metaphors can have a broad range of applications, from synthetic organic chemistry to nanotechnology platforms [36] and including biomaterials [37]. Consequently, this review provides a valuable contribution to the interest of drug discovery and molecular imaging groups.…”
Section: Kitsonmentioning
confidence: 99%
“…Admittedly, it is hard to stay on top of a still rapidly developing synthetic methodology and move to systems of biological complexity at the same time. Some opinions signify that we have a complete array of methods available with which to probe and investigate living systems, for example the use of computational methods applied to rational drug design [35].Molecular metaphors can have a broad range of applications, from synthetic organic chemistry to nanotechnology platforms [36] and including biomaterials [37]. Consequently, this review provides a valuable contribution to the interest of drug discovery and molecular imaging groups.…”
mentioning
confidence: 99%